CCR5 and mycosis fungoides: CCR5 with its ligand CCL5 has been implicated as a context-dependent axis in MF, as transcriptomic/proteomic analyses show that Vorinostat can differentially modulate CCL5/CCR5 expression across MF cell lines, highlighting disease heterogeneity and a potential link to treatment-responsive immune signaling programs [68].